FDA ANDA · ANDA220783

ROMIDEPSIN

Sponsor: ZYDUS PHARMS

What this page does not claim

A drug page is a reference view of public FDA data (Drugs@FDA), reproduced as published. SPEQ is not affiliated with the FDA, adds no interpretation to the record, and nothing here is medical, legal, or regulatory advice.

APPLICATION
ANDA220783
TYPE
ANDA
ORIGINAL APPROVAL
2026-10-19
LATEST ACTION
2026-10-19
ROUTE
INTRAVENOUS
DOSAGE FORM
POWDER
MARKETING STATUS
Prescription

Products

ROMIDEPSINPrescription
ROMIDEPSIN 10MG/VIAL · POWDER · INTRAVENOUS

Approval history

2026-10-19UNKNOWN · Original · standardAP